Nachrichten zur Pfizer Inc. Aktie

Pfizer Says Partner in China Is Gearing up for Paxlovid Sales

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer not in talks on licensing generic COVID pill in China

...NEW YORK (Reuters) - Pfizer Inc Chief Executive Albert Bourla......…

This Censorious Pfizer Board Member Was A Major Influence On Lockdowns

This Censorious Pfizer Board Member Was A Major Influence On Lockdowns …

Pfizer projects up to $84B non COVID revenue in 2030

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer working to send COVID pill Paxlovid to China - CNBC

...(Reuters) - Pfizer Inc is working with Chinese authorities... to a Reuters request for comment on…

Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly

Israel based real-world study shows that omicron-targeted COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) reduced hospitalizations among older patients. read…

UPDATE 1-U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication

... (Reuters) - The U.S. Supreme Court on Monday turned away Pfizer Incs......…

U.S. Supreme Court rebuffs Pfizer plan to help patients pay for heart medication

...WASHINGTON (Reuters) - The U.S. Supreme Court on Monday turned......…

This Stock Could Be a Surprise Growth Pick for 2023

Pfizer is about to enter a whole new era of growth....…

Pfizer Rejected by CN Medical Insurance Drug Catalogue due to High Price; CN in Talks About Producing Paxlovid Generic Drug

The negotiation on the 2022 National Medical Insurance Drug Catalogue has officially concluded yesterday (8th), China's National Healthcare Security Administration…

It’s Pharma Time: Why Merck and Lilly Are Buys, but Not Pfizer.

With rates rising, biotech has faded. Investors have favored the pharma stalwarts. Bank of America’s drug analyst Geoff Meacham runs…

Exclusive-China in talks with Pfizer for generic COVID drug - sources

...By Julie Zhu and Kevin Huang HONG KONG/BEIJING (Reuters) - China... told Reuters. Chinas medical products regulator -…

Pfizer, China in discussions to license to generic version of COVID drug Paxlovid

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This September

BioNTech, which worked with Pfizer to build an mRNA Covid vaccine, has partnered with the U.K. to turn the technology…

Pfizer Gets FDA Priority Review of Prevnar 20 for Kids >PFE

Pfizer Gets FDA Priority Review of Prevnar 20 for Kids >PFE...…

UPDATE 1-Pfizer to scale down early-stage rare disease research

...(Changes source, adds Pfizer statement) Jan 5 (Reuters) - U.S. pharma... disease and oncology," a spokesperson said in a statement to Reuters,…

BRIEF-Pfizer Says It Will Be Shifting To Invest In Rare And Benign Hematology And Platforms Such As Gene Editing Through External Innovation On Rare Conditions

...Jan 5 (Reuters) - * PFIZER SAYS WILL BE SHIFTING TO INVEST IN RARE......…

Pfizer could sell some assets, convert others into new companies amid broader refocus

Drug maker Pfizer Inc. could part with or otherwise distance itself from some of its research programs....…

Pfizer to Pull Back on Research Into Rare Disease, Gene Therapy

As part of the shift, the company may sell assets like its gene therapy facility in Durham and a cancer-focused…

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Thursday’s Top Analyst Upgrades and Downgrades: Baidu, BNY Mellon, Corning, Merck, Meta Platforms, Microsoft, Pfizer, Rivian, Target and More

Thursdays top analyst upgrades and downgrades included Baidu, Bank of New York Mellon, Charles Schwab, Corning, Livent, Merck, Meta Platforms,…

Pfizer: Downgrade

Charlotte (www.aktiencheck.de) - Rating-Update: Geoff Meacham, Analyst von BofA Securities, stuft die Aktie des Pharma-Giganten Pfizer Inc. (ISIN: US7170811035, WKN: 852009,…

As COVID vaccine and Paxlovid sales decline, analysts want to know what’s next for Pfizer

Bank of America analysts downgraded the stock to neutral from buy...…

Merck Vs. Pfizer: Why Analyst Upgrades One Pharmaceutical Stock, While Downgrading Another

The health care sector held up relatively well in a difficult year for stocks in 2022. On Wednesday, one analyst…

Why Pfizer (PFE) Could Beat Earnings Estimates Again

Pfizer (PFE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for…

Serie: Branchenausblick: Die Pharmaindustrie steht nach dem Corona-Boom vor einer Wachstumsdelle

Der Schub durch Covid-Impfstoffe und Medikamente flaut ab, gleichzeitig läuft für einige Produkte der Patentschutz ab. Novo Nordisk löst Pfizer…

Pfizer (PFE) Gains As Market Dips: What You Should Know

In the latest trading session, Pfizer (PFE) closed at $51.26, marking a +0.04% move from the previous day....…

BioNTech: Bundesregierung bemüht sich, überschüssige Impfstofflieferungen zu reduzieren - Aktienanalyse

Kulmbach (www.aktiencheck.de) - BioNTech-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von BioNTech SE (ISIN: US09075V1026,…

Tuesday’s Top Analyst Upgrades and Downgrades: Ally Financial, Apple, Block, DR Horton, EOG, Ford, Micron, PayPal, Pfizer and More

Tuesdays top analyst upgrades and downgrades included Ally Financial, Apple, Ardelyx, Block, DocuSign, D.R. Horton, Enovix, EOG Resources, Ford, Futu,…

dpa-AFX ProFeed